Observations placeholder
Pegasys and Peg-intron
Identifier
015652
Type of Spiritual Experience
Background
A description of the experience
Pegylated interferon alfa-2a (pegylated with a branched 40 kDa PEG chain; commercial name Pegasys) is an antiviral drug discovered at the pharmaceutical company F. Hoffmann-La Roche; it has a dual mode of action - both antiviral and on the immune system. The addition of polyethylene glycol to the interferon, through a process known as pegylation, enhances the half-life of the interferon when compared to its native form.
Pegylated interferon alfa-2b is a treatment for hepatitis C developed by Schering-Plough, brand name is PegIntron. It was approved in January 2001
It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
This drug is approved around the world for the treatment of chronic hepatitis C (including patients with HIV co-infection, cirrhosis, 'normal' levels of ALT) and has recently been approved (in the EU, U.S., China and many other countries) for the treatment of chronic hepatitis B.
Peginterferon alfa-2a is a long acting interferon. Interferons are proteins released in the body in response to viral infections. Interferons are important for fighting viruses in the body, for regulating reproduction of cells, and for regulating the immune system
On Jan, 13, 2017 54,565 people reported to have side effects when taking Pegasys.
Among them, 194 people (0.36%) have Hallucination
Time on Pegasys when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 32.73% | 47.27% | 18.18% | 1.82% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Pegasys :
| Female | Male | |
| Hallucination | 45.61% | 54.39% |
Age of people who have Hallucination when taking Pegasys :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 2.02% | 4.04% | 33.33% | 55.56% | 5.05% |
On Jan, 15, 2017 12,256 people reported to have side effects when taking Peginterferon. Among them, 44 people (0.36%) have Hallucination
On Dec, 31, 2016 11,138 people reported to have side effects when taking Peg-intron.
Among them, 92 people (0.83%) have Hallucination
Time on Peg-intron when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 13.56% | 59.32% | 27.12% | 0.00% | 0.00% | 0.00% | 0.00% |
Age of people who have Hallucination when taking Peg-intron :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 3.23% | 13.98% | 35.48% | 44.09% | 3.23% |